Sygen Uses, Dosage, Side Effects and more
Sygen (Sygen, AGF 2) has been investigated for the treatment of Parkinson Disease. It is a naturally occurring substance in the nerve cell’s membrane that is thought to play a role in cell growth, development, and repair. Sygen completed phase 2 trials for parkinson's disease (PD) treatment. Sygen appears to be beneficial in patients with severe spinal cord injury. Treatment results in a 52% decrease in mortality 48 hours after the induction of ischemia in gerbils by permanent unilateral ligation of the common carotid artery.
| Trade Name | Sygen |
| Generic | Siagoside |
| Siagoside Other Names | Ganglioside GM1 lactone, Siagoside, Siagosido, Siagosidum |
| Type | |
| Formula | C73H129N3O30 |
| Weight | Average: 1528.826 Monoisotopic: 1527.866089766 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
